Custom antibody fragmentation, recombinant antibody fragment expression, purification, characterization, and downstream fragment conjugation for Fab, F(ab')2, Fc, scFv, single-domain antibodies, and bispecific antibody fragments. We can also modify antibody fragments with fluorescent labels, enzymes, polymers, oligonucleotides, small molecules, and drug payloads.
Antibody fragmentation generates smaller antibody-derived formats that retain antigen recognition while changing size, valency, Fc function, tissue penetration, and conjugation behavior. These formats are useful when a full-length IgG is too large, creates Fc-mediated background, limits access to the target, or is not the best architecture for downstream labeling or payload attachment.
Our service is designed as an integrated fragment generation and fragment modification platform. Depending on the project, fragments can be prepared by enzymatic digestion of full-length antibodies or by recombinant expression of engineered antibody fragments, followed by purification, characterization, and optional conjugation.
Formats
6+ fragment classes
Fab, F(ab')2, Fc, scFv, sdAb, and bispecific fragments
Generation
Digestion + expression
Enzymatic fragmentation or recombinant expression routes
Modification
Payload-ready
Labeling, drug, polymer, oligo, and small molecule conjugation
Use
Assay to delivery
Diagnostics, imaging, ADC research, targeting, and functional studies
Fragment choice depends on the desired size, valency, Fc function, tissue access, expression route, stability, and downstream conjugation requirements.
Monovalent antigen-binding fragments commonly generated by papain digestion or recombinant expression. Useful when reduced size and removal of Fc-mediated interactions are desired.
Bivalent fragments commonly generated by pepsin digestion. They retain two antigen-binding arms while removing Fc-related activity, often improving signal-to-background in assays.
Fc-domain fragments used for Fc receptor interaction studies, controls, immune-function assays, structural analysis, and assay development.
Recombinant fragments containing linked VH and VL domains. scFv formats are useful for engineered binding tools, targeting modules, fusion designs, and fragment-based conjugates.
Compact recombinant binding domains, including sdAb or nanobody-style formats, with small size, good tissue penetration potential, and compatibility with engineered conjugation handles.
Engineered fragments designed to recognize two targets or epitopes. Useful for targeting, bridging, assay construction, and advanced therapeutic research concepts.
Full-length antibodies can be digested using enzymes such as papain for Fab generation and pepsin for F(ab')2 generation. Conditions are optimized around antibody class, species, buffer, and activity requirements.
Additional enzyme-based routes, such as IdeS-based cleavage for suitable IgG formats, may be used when specific half-antibody or defined fragment generation is required.
Engineered formats such as scFv, sdAb, and bispecific fragments can be produced through recombinant expression systems, enabling sequence-level control and scalable fragment production.
Select the best enzymatic or recombinant route based on antibody format, target application, and downstream modification needs.
Optimize enzyme ratio, time, temperature, and buffer conditions to reduce over-digestion and preserve antigen-binding activity.
Support recombinant production of engineered antibody fragments using expression systems selected according to sequence, folding, scale, and project goals.
Purify desired fragment populations and reduce intact IgG, Fc, enzyme, aggregate, or unwanted digestion products according to project scope.
Confirm fragment integrity, purity, size profile, concentration, and optional binding or functional performance depending on service design.
Modify antibody fragments after generation to create functional reagents for imaging, assays, delivery, and therapeutic research.
Fragment-based conjugation can reduce steric hindrance, improve accessibility, and create smaller targeted reagents compared with full-length antibody conjugates.
Fab, F(ab')2, scFv, or sdAb dye conjugates for microscopy, flow cytometry, immunofluorescence, and imaging.
HRP, AP, and other enzyme-fragment conjugates for ELISA, Western blot, IHC, and diagnostic detection systems.
Fragment-drug conjugates for targeted delivery and ADC research using smaller antibody formats or engineered binding fragments.
Attachment of probes, ligands, inhibitors, chelators, tags, haptens, or other small molecules to antibody fragments.
PEGylation or polymer attachment to improve solubility, stability, half-life behavior, and formulation characteristics.
Fragment-oligonucleotide conjugates for spatial biology, PCR-linked detection, proximity assays, and targeted delivery concepts.
Smaller labeled fragments can improve tissue penetration, reduce background, and support faster staining or imaging workflows.
Fragment reagents can reduce Fc-related binding and support dye, biotin, or enzyme-based detection designs.
Fragment-enzyme, fragment-biotin, or fragment-fluorophore reagents can be designed for assay development and diagnostic research.
Fragment-drug or fragment-small molecule constructs can support targeted delivery research and antibody-drug conjugate development.
Fab, scFv, sdAb, and bispecific fragments can be used to functionalize nanoparticles, liposomes, LNPs, or other delivery systems.
Fab, Fc, scFv, sdAb, and engineered fragments are useful in receptor binding, epitope mapping, structural biology, and functional assays.
These examples show how fragmentation can be combined with downstream modification to create fit-for-purpose reagents.
A customer needed to reduce Fc-related background in an immunoassay. We generated F(ab')2 fragments, purified the desired population, and conjugated the fragment to HRP.
Experimental characterization data:
Antibody format, sequence if available, species, isotype, target, and application goals
Enzymatic fragmentation or recombinant expression based on desired fragment format
Controlled digestion or expression and production of engineered fragments
Affinity, SEC, IEX, or project-specific purification to enrich desired fragment
Purity, size, concentration, and optional binding or functional testing
Dye, enzyme, drug, polymer, oligo, small molecule, or other payload attachment
For the fastest quote, include the antibody format, amount available, buffer composition, desired fragment type, final application, and whether you need downstream conjugation with a dye, enzyme, polymer, oligonucleotide, small molecule, drug, peptide, or other payload.
Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.